Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Sampling and Testing Bulk Creams before Filling – V 2.0

Posted on By

Creams: SOP for Sampling and Testing Bulk Creams before Filling – V 2.0

Standard Operating Procedure for Sampling and Testing Bulk Creams before Filling

Department Creams
SOP No. SOP/CRM/165/2025
Supersedes SOP/CRM/165/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for sampling and testing bulk creams before they are transferred to the filling process. This ensures that the cream formulation meets all quality standards, including consistency, pH, viscosity, and microbial limits, prior to packaging.

2. Scope

This SOP applies to the process of sampling and testing bulk cream batches just before they are transferred to the filling machines. It covers sampling techniques, the required tests, and documentation procedures to ensure product quality and compliance with specifications.

3. Responsibilities

  • Production Team: Responsible for providing the bulk cream samples at the correct stage of production and ensuring that the sample volume is sufficient for the required tests.
  • Quality Control (QC) Team: Responsible for performing the tests on the bulk cream samples, documenting the results, and ensuring that the product meets specifications before it proceeds to filling.
  • Laboratory Supervisor: Responsible for overseeing the testing process, ensuring compliance with the
SOP, and approving or rejecting the bulk cream based on test results.

4. Accountability

The Production Manager is accountable for ensuring that the bulk cream samples are provided in a timely manner and at the correct stage of production. The QC Manager is accountable for overseeing the sampling and testing process. The Laboratory Supervisor is accountable for reviewing test results and making decisions based on those results.

5. Procedure

5.1 Pre-Sampling Setup

  1. Ensure that the production process has been completed, and the cream is ready for testing before it is transferred to filling machines.
  2. Ensure that the sampling area and equipment are clean and sanitized in accordance with GMP guidelines.
  3. Ensure that the sampling containers are clean, sterile, and suitable for collecting representative samples of the bulk cream.
  4. Verify that the QC team has access to the necessary testing equipment (e.g., viscometer, pH meter, microbiological testing kits) to perform the required tests on the bulk cream samples.

5.2 Sampling Procedure

  1. Take representative samples of the bulk cream from different parts of the batch to ensure uniformity. A minimum of three samples should be taken from different locations within the batch.
  2. Ensure that each sample is of sufficient volume to allow for all required tests (e.g., viscosity, pH, microbial testing, appearance testing). The sample volume should meet the requirements as outlined in the BMR or product specifications.
  3. Label the samples with the batch number, sampling date, time, and any other necessary identifiers for traceability.
  4. Immediately transfer the samples to the QC laboratory for testing. Samples should not be left exposed to contamination or temperature fluctuations.

5.3 Testing Procedure

  1. Viscosity Test: Measure the viscosity of the bulk cream using a calibrated viscometer. Ensure that the viscosity falls within the specified range as defined in the BMR or product specifications.
  2. pH Test: Measure the pH of the bulk cream using a calibrated pH meter. Ensure that the pH is within the acceptable range as specified in the product specifications.
  3. Microbial Testing: Conduct microbial testing, including tests for total viable count (TVC), yeast and mold count, and any specific microorganisms specified in the product specifications.
  4. Appearance Test: Visually inspect the bulk cream for consistency, color, and texture. The cream should appear uniform, with no visible separation or clumping.
  5. Ensure that all test results are recorded accurately in the Testing Log (Annexure-1) and compared against the product specifications. If any test results fall outside the acceptable range, initiate the deviation procedure as described in the Deviation Report (Annexure-2).

5.4 Handling Deviations

  1. If any test results do not meet the required specifications, document the deviation in the Deviation Report (Annexure-2).
  2. Investigate the cause of the deviation, which may include checking the formulation, production conditions, or equipment.
  3. Implement corrective actions, which may include reworking the batch, adjusting ingredients, or modifying the production process.
  4. For any critical deviations that affect product quality, halt the production and filling process until the issue is resolved.
  5. Ensure that all deviations are thoroughly documented and reviewed by the QA and Laboratory Supervisors.

5.5 Post-Sampling and Testing

  1. Once the testing is complete, ensure that the bulk cream meets all required specifications (e.g., viscosity, pH, microbial limits, and appearance) before it proceeds to the filling stage.
  2. If the bulk cream passes all tests, approve the batch for filling and packaging, and document the approval in the Batch Production Log (Annexure-3).
  3. If the bulk cream fails any tests, reject the batch or initiate the rework process as per the Batch Rework SOP (SOP/CRM/004/2025).
  4. Ensure that the production team is notified of the test results and the next steps for either continuing or halting the production process.

5.6 Documentation and Record-Keeping

  1. Record all sampling and testing data in the Testing Log (Annexure-1), ensuring that all information is accurate and complete.
  2. Document any deviations and corrective actions in the Deviation Report (Annexure-2).
  3. Maintain all sampling and testing records for a minimum of two years or as required by regulatory guidelines.
  4. Ensure that all records are reviewed and signed by the Laboratory Supervisor and other relevant personnel, and stored securely for easy retrieval during audits.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • pH: Potential Hydrogen
  • TVC: Total Viable Count

7. Documents

  1. Annexure-1: Testing Log
  2. Annexure-2: Deviation Report
  3. Annexure-3: Batch Production Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Sampling and Testing of Cream Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Testing Log

Batch Number Test Type Test Result Operator Remarks
12345 Viscosity 85 cP John Doe Pass

Annexure-2: Deviation Report

Batch Number Deviation Description Corrective Action Resolved By
12345 Viscosity failed Adjusted ingredients Jane Smith

Annexure-3: Batch Production Log

Batch Number Production Date Operator Approval Status
12345 21/01/2026 John Doe Approved

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Conducting Endotoxin Testing for Cream Products - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Gel Manufacturing: SOP for Maintaining Temperature Controllers in Production – V 2.0
Next Post: SOP for Conducting Quality Metrics Analysis

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version